Structural brain changes in patients with Huntington's disease participating in a randomized, double-blind, placebo-controlled trial of ethyl-eicosapentaenoic acid
Main Authors: | Beckmann Christian F, Manku Mehar S, Clarke Anthony, Bydder Graeme M, Puri Basant K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | Annals of General Psychiatry |
Similar Items
-
Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.
by: Harald Gelderblom, et al.
Published: (2017-01-01) -
EPA and Huntington's chorea: treatment and associated cerebral changes
by: Puri Basant K
Published: (2010-04-01) -
Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study
by: Christie M. Ballantyne, et al.
Published: (2019-02-01) -
The Effect of Eicosapentaenoic Acid Supplementation on Depression Remission: a Double-Blind Randomized Clinical Trial
by: Karamati, et al.
Published: (2011-12-01) -
Some biological effects of prolactin on renal function and on smooth muscle
by: Manku, Mehar S.
Published: (1975)